medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2024, Number 3

<< Back Next >>

Acta Ortop Mex 2024; 38 (3)

Delayed diagnosis of osteosarcoma in adults: a prognostic factor to be considered

Clara-Altamirano M, García-Ortega D, Álvarez-Cano A, Velázquez-Rodríguez S, Lizcano-Suárez A, Rosas L, Uribe-Saloma C, Martínez-Said H, Villavicencio-Valencia V, Cuellar-Hubbe M

Language: Spanish
References: 27
Page: 164-171
PDF size: 176.61 Kb.


ABSTRACT

Introduction: different variables have been associated with a worse prognosis of patients with osteosarcoma (OS), highlighting tumor size, location in the axial skeleton and the presence of metastases. The objective of this study is to analyze the prognostic impact of diagnostic delay in osteosarcoma in adults in the Mexican population in a center specialized in sarcomas. Material and methods: retrospective cohort study from January 1, 2005, to December 31, 2016, 96 patients over 21 years of age with a diagnosis of osteosarcoma were analyzed. Results: the median time to diagnosis from the onset of symptoms was six months (range: 2-36). This variable was dichotomized by applying the operator-dependent curve (ROC) analysis and we determined a cut-off value greater than five months, with an area under the curve (AUC) = 0.93 [95% CI 0.86-0.97], sensitivity 93.2% and specificity 94.6%. Conclusion: time until diagnosis is a critical factor in the survival of adult patients with osteosarcoma, highlighting its influence on disease progression and the appearance of metastasis. The correlation between diagnostic delay and an unfavorable prognosis reinforces the need for rapid and efficient evaluation in suspected cases of osteosarcoma.


REFERENCES

  1. Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma overview. Rheumatol Ther. 2017; 4(1): 25-43.

  2. Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, et al. Molecular biology of osteosarcoma. Cancers (Basel). 2020; 12(8): 2130.

  3. Carsi B, Rock MG. Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res. 2002; 397: 53-61.

  4. Jeon DG, Lee SY, Cho WH, Song WS, Park JH. Primary osteosarcoma in patients older than 40 years of age. J Korean Med Sci. 2006; 21(4): 715-8.

  5. Kumar R, Kumar M, Malhotra K, Patel S. Primary osteosarcoma in the elderly revisited: current concepts in diagnosis and treatment. Curr Oncol Rep. 2018; 20(2): 13.

  6. Iwata S, Ishii T, Kawai A, Hiruma T, Yonemoto T, Kamoda H, et al. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases. Ann Surg Oncol. 2014; 21(1): 263-8.

  7. Nishida Y, Isu K, Ueda T, Nishimoto Y, Tsuchiya H, Wada T, et al. Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese musculoskeletal oncology group. J Surg Oncol. 2009; 100(1): 48-54.

  8. Haddox CL, Han G, Anijar L, Binitie O, Letson GD, Bui MM, et al. Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome. Sarcoma. 2014; 2014: 402509.

  9. Eaton BR, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato DJ, Laack N. Osteosarcoma. Pediatr Blood Cancer. 2021; 68 Suppl 2: e28352.

  10. Rodriguez FJH, Tecualt GR, Amaya ZRA, Atencio CA, Cario MAG, González VR. Comportamiento epidemiológico del osteosarcoma en la población mexicana entre 2005 y 2014. [Epidemiologic behavior of osteosarcoma in Mexican population from 2005 to 2014]. Revista De La Asociación Argentina De Ortopedia Y Traumatología. 2016; 81(3): 219-26.

  11. Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al. AJCC cancer staging manual. In: Amin MB, Edge SB, Greene FL eds. AJCC cancer staging manual. New York: Springer. 2017.

  12. Dharanikota A, Arjunan R, Dasappa A. Factors affecting prognosis and survival in extremity osteosarcoma. Indian J Surg Oncol. 2021; 12(1): 199-206.

  13. Allison DC, Carney SC, Ahlmann ER, Hendifar A, Chawla S, Fedenko A, et al. A meta-analysis of osteosarcoma outcomes in the modern medical era. Sarcoma. 2012; 2012: 704872.

  14. Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma. J Bone Joint Surg Am. 2013; 95(13): e89.

  15. Simpson E, Brown HL. Understanding osteosarcomas. JAAPA. 2018; 31(8): 15-19.

  16. Pérez-Bañuelos A, Palomo-Collí MA, Sadowinski-Pine S, Mier-Cabrera M. Disparidades en el cumplimiento de los protocolos de tratamiento en pacientes con osteosarcoma. Gac Mex Oncol. 2020; 19(4): 114-20.

  17. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - Where do we stand? A state of the art review. Cancer Treat Rev. 2014; 40(4): 523-32. Available in: http://dx.doi.org/10.1016/j.ctrv.2013.11.006

  18. Zhang Y, He Z, Duan Y, Wang C, Kamar S, Shi X, et al. Does intensified chemotherapy increase survival outcomes of osteosarcoma patients? A meta-analysis. J Bone Oncol. 2018; 12: 54-60.

  19. Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg. 2016; 82(4): 690-8.

  20. Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016; 47(1): 283-92. Available in: http://dx.doi.org/10.1016/j.ocl.2015.08.022

  21. Bielack SS, Hecker-Nolting S, Blattmann C, Kager L. Advances in the management of osteosarcoma. F1000Res. 2016; 5: 2767.

  22. Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018; 18(1): 39-50. Available in: http://dx.doi.org/10.1080/14737140.2018.1413939

  23. Brookes MJ, Chan CD, Baljer B, Wimalagunaratna S, Crowley TP, Ragbir M, et al. Surgical advances in osteosarcoma. Cancers (Basel). 2021; 13(3): 388.

  24. Li X, Zhang Y, Wan S, Li H, Li D, Xia J, et al. A comparative study between limb-salvage and amputation for treating osteosarcoma. J Bone Oncol. 2016; 5(1): 15-21.

  25. He X, Gao Z, Xu H, Zhang Z, Fu P. A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes. J Orthop Surg Res. 2017; 12(1): 5. Available in: http://dx.doi.org/10.1186/s13018-016-0500-0

  26. Jeys LM, Thorne CJ, Parry M, Gaston CLL, Sumathi VP, Grimer JR. A novel system for the surgical staging of primary high-grade osteosarcoma: the birmingham classification. Clin Orthop Relat Res. 2017; 475(3): 842-50.

  27. Han G, Bi WZ, Xu M, Jia JP, Wang Y. Amputation versus limb-salvage surgery in patients with osteosarcoma: a meta-analysis. World J Surg. 2016; 40(8): 2016-27.



EVIDENCE LEVEL

II




2020     |     www.medigraphic.com